From: The prevalence of obstructive sleep apnea in Japanese asthma patients
Characteristics | Â |
---|---|
Male/Female, n (%) | 13 (24.5)/40 (75.5) |
Age, years | 59.0 ± 16.4 |
Age at asthma onset, years | 36.8 ± 22.9 |
BMI, kg/m2 | 26.4 ± 6.2 |
Smoking status: Never/Ex./Current, n (%) | 29 (54.7)/14 (26.4)/10 (18.9) |
Smoking history, pack-year | 12.1 ± 18.9 |
Hypertension, n (%) | 19 (35.8) |
Diabetes, n (%) | 14 (26.4) |
BNP, pg/ml | 40.4 ± 79.3 |
GINA step 1/2/3/4/5, n (%) | 0/1/16/26/10 (0/1.9/30.2/49.1/18.9) |
Allergic rhinitis, n (%) | 25 (47.2) |
FSSG score | 8.13 ± 9.0 |
ACT score | 21.6 ± 3.8 |
ACQ-6 | 0.9 ± 0.8 |
FeNO (ppb) | 39.8 ± 38.6 |
Peripheral blood neutrophil count, cells/µL | 4198.7 ± 1898.6 |
Peripheral blood eosinophil count, cells/µL | 377.0 ± 762.6 |
Serum IgE level, IU/mL | 820.6 ± 1997.5 |
FVC, L | 2.8 ± 0.7 |
FVC, % of predicted | 99.7 ± 15.0 |
FEV1, L | 2.0 ± 0.6 |
FEV1, % of predicted | 85.9 ± 18.4 |
FEV1/FVC, % | 70.8 ± 12.1 |
MMF, L | 1.4 ± 1.1 |
MMF, % of predicted | 47.2 ± 30.4 |